6550--PHADIA 250 REAGENT AND CONSUMABLES
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.246-NETWORK CONTRACTING OFFICE 6 (36C246)
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 31, 2026
- Closes
- Sep 4, 2026 (in 4 days)
Similar opportunities open now
- 6640--ROCHE COBAS LIAT REAGENTS AND CONSUMABLESOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- J066--ROCHE COBAS LIAT SERVICEOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- 6550--HOLOGIC PANTHER SUPPLIES & CONSUMABLES IDC SALISBURYOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- AN41--523-26-4-1865-0151: 10X Xenium Analyzer Recertification and PM (VA-26-00073846)OpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- 6632--GENEXPERT 16-MODULE SYSTEM at Durham VAMCOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by VETERANS AFFAIRS, DEPARTMENT OF in the in-vitro diagnostic substance manufacturing category. The deadline is September 4, 2026, 5 days from now.
Classification and identifiers
- Industry (NAICS)
- In-Vitro Diagnostic Substance Manufacturing (325413)
- Product or service (PSC)
- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (6550)
- Solicitation number
- 36C24626Q0972
Who can apply
About this opportunity
The Department of Veterans Affairs, Network Contracting Office (NCO) 6 intends to award a sole source, firm fixed price contract to Fisher Scientific Company LLC (LB), 11450 Compaq Center West Dr St., Houston, TX, 77070 for the Phadia 250 associated reagents and consumables for the Fayetteville VAMC located at 2300 Ramsey Street, Fayetteville, NC, 28301. The Phadia 250 instrument is currently owned by the Fayetteville VAMC and Fisher Scientific Company LLC (LB) a branch Thermo Fisher Scientific (LB) (OEM) is the sole authorized source for the procurement of the Phadia 250 instrument and its associated reagents and consumables. Market research has determined that these items can only be obtained from a single source without an unacceptable duplication of cost or delay in the continuity of p...